Total Payments
$6,705
2024 Payments
$791.33
Companies
28
Transactions
300
Medicare Patients
1,725
Medicare Billing
$203,885
Payment Breakdown by Category
Food & Beverage$6,530 (97.4%)
Education$174.98 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,530 | 297 | 97.4% |
| Education | $174.98 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,039 | 41 | $0 (2024) |
| Merck Sharp & Dohme LLC | $641.41 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $484.15 | 29 | $0 (2024) |
| PFIZER INC. | $431.13 | 26 | $0 (2024) |
| Astellas Pharma US Inc | $430.69 | 16 | $0 (2022) |
| CSL Behring | $429.47 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $385.35 | 24 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $347.85 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $334.25 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $294.41 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $791.33 | 33 | ABBVIE INC. ($189.74) |
| 2023 | $1,647 | 74 | Alexion Pharmaceuticals, Inc. ($292.19) |
| 2022 | $911.13 | 40 | Janssen Pharmaceuticals, Inc ($218.58) |
| 2021 | $470.01 | 20 | Astellas Pharma US Inc ($192.99) |
| 2020 | $249.50 | 14 | Janssen Pharmaceuticals, Inc ($106.98) |
| 2019 | $1,194 | 54 | Merck Sharp & Dohme Corporation ($345.50) |
| 2018 | $918.35 | 52 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($118.69) |
| 2017 | $523.75 | 13 | Novartis Pharmaceuticals Corporation ($161.58) |
All Payment Transactions
300 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/24/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/23/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ANTIFUNGALS | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/30/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/27/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Infections and Infectious Diseases | ||||||
| 09/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/15/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $29.89 | General |
| Category: Cardiovascular | ||||||
| 06/24/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: DIABETES | ||||||
| 05/21/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: DIABETES | ||||||
| 05/14/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Rare Disease | ||||||
| 04/12/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: DIABETES | ||||||
| 03/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/28/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 03/26/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/06/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: ANTIBIOTIC | ||||||
| 02/22/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $36.33 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 384 | 632 | $141,024 | $46,421 |
| 2022 | 3 | 374 | 612 | $104,885 | $41,536 |
| 2021 | 4 | 485 | 717 | $112,050 | $59,453 |
| 2020 | 5 | 482 | 739 | $111,820 | $56,474 |
Total Patients
1,725
Total Services
2,700
Medicare Billing
$203,885
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 179 | 352 | $65,539 | $21,531 | 32.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 133 | 208 | $55,677 | $18,817 | 33.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 72 | 72 | $19,807 | $6,072 | 30.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 156 | 256 | $49,144 | $19,791 | 40.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 148 | 285 | $39,894 | $15,915 | 39.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 70 | 71 | $15,848 | $5,830 | 36.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 181 | 271 | $43,360 | $23,875 | 55.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 176 | 317 | $36,455 | $19,352 | 53.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 59 | 59 | $18,585 | $10,131 | 54.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 69 | 70 | $13,650 | $6,095 | 44.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 202 | 401 | $46,115 | $23,547 | 51.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 138 | 194 | $31,075 | $16,389 | 52.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 59 | 60 | $18,900 | $9,598 | 50.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 70 | 71 | $13,845 | $6,161 | 44.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 13 | 13 | $1,885 | $779.98 | 41.4% |
About Akua Fordjour, MD, PHD
Akua Fordjour, MD, PHD is a Hospitalist healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1285040626.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Akua Fordjour, MD, PHD has received a total of $6,705 in payments from pharmaceutical and medical device companies, with $791.33 received in 2024. These payments were reported across 300 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,530).
As a Medicare-enrolled provider, Fordjour has provided services to 1,725 Medicare beneficiaries, totaling 2,700 services with total Medicare billing of $203,885. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Hospitalist, Hospitalist
- Location Dallas, TX
- Active Since 07/07/2014
- Last Updated 01/13/2026
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1285040626
Products in Payments
- XARELTO (Drug) $1,039
- ELIQUIS (Drug) $730.25
- Kcentra (Biological) $429.47
- ULTOMIRIS (Biological) $347.85
- DIFICID (Drug) $306.14
- ENTRESTO (Drug) $294.41
- ZERBAXA (Drug) $288.18
- JARDIANCE (Drug) $277.71
- XIFAXAN (Drug) $273.52
- Fetroja (Drug) $262.08
- Veltassa (Drug) $250.06
- REBYOTA (Biological) $249.76
- LOKELMA (Drug) $241.21
- CRESEMBA (Drug) $190.43
- TEFLARO (Drug) $135.55
- OZURDEX (Drug) $124.37
- Otezla (Drug) $115.18
- PRADAXA (Drug) $107.64
- CHANTIX (Drug) $100.60
- DALVANCE (Drug) $73.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Dallas
Dr. Ali Bagheri, Md, MD
Hospitalist — Payments: $11,446
Hospitalist $11,446
Janae' Richard
Hospitalist — Payments: $9,928
Hospitalist $9,928
Dr. Anita Khetan, M.d, M.D
Hospitalist — Payments: $9,685
Hospitalist $9,685
Rainer Khetan, M.d, M.D
Hospitalist — Payments: $8,606
Hospitalist $8,606
Dr. Radha Yalamanchili, Md, MD
Hospitalist — Payments: $6,937
Hospitalist $6,937
Amy Gates, Md, MD
Hospitalist — Payments: $6,891
Hospitalist $6,891